Arcturus Therapeutics (ARCT) Prices 3.26M Share Common Offering at $53/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St recovers as yields ease; Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
After-Hours Movers 07/28: (BGFV) (KODK) (AMD) Higher; (KODK) (RRD) (STX) Lower (more...)
July 28, 2020 6:04 PM EDTToday's After-Hours Movers
Big 5 Sporting Goods (NASDAQ: BGFV) 47% HIGHER; reported Q2 EPS of $0.52, versus $0.00 reported last year. Revenue for the quarter came in at $227.94 million, versus $240.97 million reported last year.
Eastman Kodak Company (NYSE: KODK) 36% HIGHER; adds to 200%+ intra-day gains as Trump mentioned the deal to produce drug ingredients
Community Health Systems (NYSE: CYH) 16.5% HIGHER; reported Q2 EPS of $0.85, $1.47 better than the analyst estimate of ($0.62). Revenue for... More
Arcturus Therapeutics (ARCT) Announces Proposed Public Offering of Common Stock
July 28, 2020 4:15 PM EDTArcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares... More
Arcturus Therapeutics (ARCT) PT Raised to $78 at H.C. Wainwright
July 27, 2020 6:36 AM EDTH.C. Wainwright analyst Ed Arce raised the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $78.00 (from $62.00) while maintaining a Buy rating.... More
